Prulifloxacin compound preparation

A technology of prulifloxacin and compound preparations, which is applied in pill delivery, pharmaceutical formulations, medical preparations containing active ingredients, etc., to achieve good synergistic effect, uniform distribution, and wide application range
CN1836662AInactive Publication Date: 2006-09-27夏中宁

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
夏中宁
Publication Date
2006-09-27
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The compound prulifloxicin preparation is used in treating bacterial infectious diseases. The compound prulifloxicin preparation consists of prulifloxicin 50-600 mg, pidaomode 200-1600 mg and pharmaceutically acceptable supplementary material, and is prepared into various pharmaceutically acceptable preparation forms for treating bacterial infectious diseases clinically. It can raise bodyí»s immunity level to strengthen the exogenous bactericidal effect of prulifloxicin.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a prulifloxacin compound preparation for treating bacterial infectious diseases. Background technique

[0002] Prulifloxacin (Prulifloxacin) is a fourth-generation quinolone antibacterial drug developed by Japan New Drug Company. Its chemical name is: 6-fluoro-1-methyl-7-[4-(5-methyl-2- Oxo-1,3-dioxol-4-yl)methyl-1-piperazinyl]-4-oxo-4H-[1,3]thiazetidine[3, 2-a] Quinoline-3-carboxylic acid, molecular formula: C 21 h 20 FN 3 o 6 S, molecular weight: 461.46. Prulifloxacin has excellent pharmacokinetic and pharmacodynamic characteristics, broad antibacterial spectrum, few side effects, and is not easy to develop drug resistance. It has good curative effect in clinical treatment of bacterial infections. However, in recent years, due to the increase of bacterial resistance due to the extensive use of antibiotics, the clinical treatment of bacterial infections has been plagued by problems such as complexity, refractory and repe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More